BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 31722730)

  • 1. P2Y12 receptor mediates microglial activation via RhoA/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine.
    Jing F; Zhang Y; Long T; He W; Qin G; Zhang D; Chen L; Zhou J
    J Neuroinflammation; 2019 Nov; 16(1):217. PubMed ID: 31722730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of microglial GLP-1R in the trigeminal nucleus caudalis suppresses central sensitization of chronic migraine after recurrent nitroglycerin stimulation.
    Jing F; Zou Q; Wang Y; Cai Z; Tang Y
    J Headache Pain; 2021 Jul; 22(1):86. PubMed ID: 34325647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR2 Mediates Microglial Activation and Contributes to Central Sensitization in a Recurrent Nitroglycerin-induced Chronic Migraine Model.
    Liu X; Yang W; Zhu C; Sun S; Yang B; Wu S; Wang L; Liu Z; Ge Z
    Mol Neurobiol; 2024 Jun; 61(6):3697-3714. PubMed ID: 38008889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia P2X4 receptor contributes to central sensitization following recurrent nitroglycerin stimulation.
    Long T; He W; Pan Q; Zhang S; Zhang Y; Liu C; Liu Q; Qin G; Chen L; Zhou J
    J Neuroinflammation; 2018 Aug; 15(1):245. PubMed ID: 30165876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model.
    Long T; He W; Pan Q; Zhang S; Zhang D; Qin G; Chen L; Zhou J
    J Headache Pain; 2020 Jan; 21(1):4. PubMed ID: 31937253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model.
    He W; Long T; Pan Q; Zhang S; Zhang Y; Zhang D; Qin G; Chen L; Zhou J
    J Neuroinflammation; 2019 Apr; 16(1):78. PubMed ID: 30971286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-155-5p promotes neuroinflammation and central sensitization via inhibiting SIRT1 in a nitroglycerin-induced chronic migraine mouse model.
    Wen Q; Wang Y; Pan Q; Tian R; Zhang D; Qin G; Zhou J; Chen L
    J Neuroinflammation; 2021 Dec; 18(1):287. PubMed ID: 34893074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2X7R-mediated autophagic impairment contributes to central sensitization in a chronic migraine model with recurrent nitroglycerin stimulation in mice.
    Jiang L; Zhang Y; Jing F; Long T; Qin G; Zhang D; Chen L; Zhou J
    J Neuroinflammation; 2021 Jan; 18(1):5. PubMed ID: 33402188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Microglial P2Y12 Signaling in Tongue Cancer Pain.
    Tamagawa T; Shinoda M; Honda K; Furukawa A; Kaji K; Nagashima H; Akasaka R; Chen J; Sessle BJ; Yonehara Y; Iwata K
    J Dent Res; 2016 Sep; 95(10):1176-82. PubMed ID: 27151915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroacupuncture improves allodynia and central sensitization via modulation of microglial activation associated P2X4R and inflammation in a rat model of migraine.
    Zhou M; Pang F; Liao D; Yang Y; Wang Y; Yang Z; He X; Tang C
    Mol Pain; 2024; 20():17448069241258113. PubMed ID: 38744426
    [No Abstract]   [Full Text] [Related]  

  • 11. P2Y12 regulates microglia activation and excitatory synaptic transmission in spinal lamina II neurons during neuropathic pain in rodents.
    Yu T; Zhang X; Shi H; Tian J; Sun L; Hu X; Cui W; Du D
    Cell Death Dis; 2019 Feb; 10(3):165. PubMed ID: 30778044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoA/ROCK pathway mediates p38 MAPK activation and morphological changes downstream of P2Y12/13 receptors in spinal microglia in neuropathic pain.
    Tatsumi E; Yamanaka H; Kobayashi K; Yagi H; Sakagami M; Noguchi K
    Glia; 2015 Feb; 63(2):216-28. PubMed ID: 25130721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
    Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
    Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of DLC2 and RhoA/ROCK pathway in formalin induced inflammatory pain in mice.
    Wong SSC; Lee UM; Wang XM; Chung SK; Cheung CW
    Neurosci Lett; 2019 Sep; 709():134379. PubMed ID: 31323253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of P2Y
    Gölöncsér F; Baranyi M; Iring A; Hricisák L; Otrokocsi L; Benyó Z; Sperlágh B
    Br J Pharmacol; 2021 Dec; 178(23):4626-4645. PubMed ID: 34363208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin gene-related peptide facilitates sensitization of the vestibular nucleus in a rat model of chronic migraine.
    Zhang Y; Zhang Y; Tian K; Wang Y; Fan X; Pan Q; Qin G; Zhang D; Chen L; Zhou J
    J Headache Pain; 2020 Jun; 21(1):72. PubMed ID: 32522232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of different outcome measures for the nitroglycerin model of migraine in mice.
    Farkas S; Bölcskei K; Markovics A; Varga A; Kis-Varga Á; Kormos V; Gaszner B; Horváth C; Tuka B; Tajti J; Helyes Z
    J Pharmacol Toxicol Methods; 2016; 77():33-44. PubMed ID: 26456070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia TREM1-mediated neuroinflammation contributes to central sensitization via the NF-κB pathway in a chronic migraine model.
    Sun S; Fan Z; Liu X; Wang L; Ge Z
    J Headache Pain; 2024 Jan; 25(1):3. PubMed ID: 38177990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Kinase C γ Contributes to Central Sensitization in a Rat Model of Chronic Migraine.
    Wu B; Wang S; Qin G; Xie J; Tan G; Zhou J; Chen L
    J Mol Neurosci; 2017 Oct; 63(2):131-141. PubMed ID: 28842814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dualistic role of the purinergic P2Y12-receptor in an in vivo model of Parkinson's disease: Signalling pathway and novel therapeutic targets.
    Iring A; Tóth A; Baranyi M; Otrokocsi L; Módis LV; Gölöncsér F; Varga B; Hortobágyi T; Bereczki D; Dénes Á; Sperlágh B
    Pharmacol Res; 2022 Feb; 176():106045. PubMed ID: 34968684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.